Purchases and Sales Made in Q3 2023 in Context Therapeutics Inc. (CNTX)
This table provides information about the institutional ownership of Context Therapeutics Inc. (CNTX) during Q3 2023. The information is specifically focused on institutions that hold shares of Context Therapeutics Inc..
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Nov 14, 2023
Q3 2023
|
Ubs Oconnor LLC
Chicago, IL |
BUY
|
- |
230K+ 350.57% |
$207K - $366K
|
296K
$334K
|
|
|
Nov 14, 2023
Q3 2023
|
Ally Bridge Group (Ny) LLC
New York, NY |
BUY
|
- |
72.6K+ 11.1% |
$65.3K - $115K
|
726K
$820K
|
|
|
Nov 14, 2023
Q3 2023
|
Affinity Asset Advisors, LLC
New York, NY |
BUY
|
- |
61.2K+ 22.89% |
$55.1K - $97.4K
|
329K
$372K
|
|
|
Nov 14, 2023
Q3 2023
|
Vanguard Group Inc
Valley Forge, PA |
BUY
|
- |
18.8K+ 3.27% |
$16.9K - $29.9K
|
593K
$671K
|
|
|
Nov 13, 2023
Q3 2023
|
Xtx Topco LTD
London, X0 |
BUY
|
- |
13.3KNew |
$11.9K - $21.1K
|
13.3K
$15K
|
|
|
Nov 14, 2023
Q3 2023
|
Ken Griffin
Citadel Advisors LLC | Chicago, Il
|
BUY
|
- |
10.4KNew |
$9.39K - $16.6K
|
10.4K
$11.8K
|
|
|
Nov 14, 2023
Q3 2023
|
Tower Research Capital LLC (Trc)
New York, NY |
BUY
|
- |
3.03K+ 50.97% |
$2.72K - $4.81K
|
8.96K
$10.1K
|
|
|
Nov 14, 2023
Q3 2023
|
Jim Simons
Renaissance Technologies LLC | New York, Ny
|
BUY
|
- |
1.8K+ 6.36% |
$1.62K - $2.86K
|
30.1K
$34K
|
|
|
Nov 14, 2023
Q3 2023
|
Jpmorgan Chase & CO
New York, NY |
BUY
|
- |
16New |
$14.4 - $25.4
|
16
$18.1
|
|
|
Nov 13, 2023
Q3 2023
|
Wells Fargo & Company
San Francisco, CA |
BUY
|
- |
1+ 0.93% |
$0.9 - $1.59
|
108
$122
|
|
|
Oct 30, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Oct 25, 2023
Q3 2023
|
Concourse Financial Group Securities, Inc.
Birmingham, AL |
BUY
|
- |
0New |
$0 - $0
|
0
$0
|
|
|
Nov 13, 2023
Q3 2023
|
Geode Capital Management, LLC
Boston, MA |
SELL
|
- |
-9.99K- 9.32% |
$8.99K - $15.9K
|
97.2K
$110K
|